Press Release

Illumina to Announce Third Quarter 2010 Financial Results on Tuesday, October 26, 2010

SAN DIEGO, Oct 12, 2010 (BUSINESS WIRE) -- Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for third quarter 2010 following the close of market on Tuesday, October 26, 2010.

On the same day, at 2:30pm Pacific Time (5:30pm Eastern Time), Jay Flatley, President and Chief Executive Officer, and Christian Henry, Senior Vice President, Chief Financial Officer, and General Manager, Life Sciences, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results.

Conference Call Details

The conference call will begin at 2:30pm Pacific Time (5:30pm Eastern Time) on Tuesday, October 26, 2010. Interested parties may listen to the call by dialing 800.291.5365 (passcode: 77315540), or if outside North America, by dialing +1.617.614.3922 (passcode: 77315540). Individuals may access the live teleconference under the "Corporate/Investor Information" tab of Illumina's web site at http://www.illumina.com.

A replay of the conference call will be available from 6:30pm Pacific Time (9:30pm Eastern Time) on October 26, 2010 through November 2, 2010 by dialing 888.286.8010, or if outside North America, by dialing +1.617.801.6888 (passcode: 18304626).

About Illumina

Illumina (http://www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare.

SOURCE: Illumina, Inc.

Illumina, Inc.
Investors:
Peter J. Fromen
Sr. Director, Investor Relations
+858-202-4507
pfromen@illumina.com
or
Media:
Wilson Grabill
Sr. Manager, Public Relations
+858-882-6822
wgrabill@illumina.com

Recent Articles

Early access users rave about Illumina’s new MiSeq i100 Series
Early access users rave about Illumina’s new MiSeq i100 Series
Trailblazing study shows early CGP leads to better precision treatments
Trailblazing study shows early CGP leads to better precision treatments
How two systems integration scientists ensure a smooth workflow on MiSeq i100
How two systems integration scientists ensure a smooth workflow on MiSeq i100